Publication
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
Journal Paper/Review - Jun 28, 2022
Huober Jens, Zhang Hong, Restuccia Eleonora, Lambertini Chiara, Gochitashvili Nino, Henschel Volkmar, Eiger Daniel, Graupner Vilma, Zhukova Lyudmila, Pedrini José, Huggins-Puhalla Shannon L, Chang Yuan-Ching, Jarząb Michał, Niikura Naoki, Barrios Carlos H, IMpassion050 Trial Investigators
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Barrios, Carlos H
1
0
Niikura, Naoki
1
0
Jarząb, Michał
1
0
Chang, Yuan-Ching
1
0
Huggins-Puhalla, Shannon L
1
0
Pedrini, José
1
0
Zhukova, Lyudmila
1
0
Graupner, Vilma
1
0
Eiger, Daniel
1
0
Henschel, Volkmar
1
0
Gochitashvili, Nino
1
0
Lambertini, Chiara
1
0
Restuccia, Eleonora
1
0
Zhang, Hong
2
0
IMpassion050 Trial Investigators,
1
0